Comment on: Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis. Reply

Rheumatology (Oxford). 2021 Jul 1;60(7):e260-e261. doi: 10.1093/rheumatology/keab136.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Antiphospholipid
  • Antiphospholipid Syndrome* / complications
  • Atherosclerosis* / epidemiology
  • Atherosclerosis* / etiology
  • Female
  • Humans
  • Pregnancy

Substances

  • Antibodies, Antiphospholipid